Mesoridazine

In the US, Mesoridazine (mesoridazine systemic) is a member of the drug class phenothiazine antipsychotics and is used to treat Schizophrenia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AC03

CAS registry number (Chemical Abstracts Service)

0005588-33-0

Chemical Formula

C21-H26-N2-O-S2

Molecular Weight

386

Therapeutic Category

Neuroleptic

Chemical Name

10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-

Foreign Names

  • Mesoridazinum (Latin)
  • Mesoridazin (German)
  • Mésoridazine (French)
  • Mesoridazina (Spanish)

Generic Names

  • Mesoridazine (OS: BAN, USAN)
  • Mésoridazine (OS: DCF)
  • NC 123 (IS)
  • TPS 23 (IS)
  • Mesoridazine methylsulfonate (IS)

Brand Name

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)